Piedad, Maricel .

HRN: 07-41-87  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2023
AMPICILLIN 1GM (VIAL)
03/30/2023
04/01/2023
IV
2gm
Q6
PROM, UTI, Pus Cells TNTC
Waiting Final Action 
03/31/2023
CEFUROXIME 1.5GM (VIAL)
03/31/2023
04/02/2023
IV
1.5grams
Q8 X 6 Doses
S/p Primary Cs
Waiting Final Action 
03/31/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/31/2023
04/02/2023
IV
500mg
Loading Dose
S/p Primary Cs
Waiting Final Action 
04/01/2023
CEFUROXIME 500MG (TAB)
04/02/2023
04/09/2023
ORAL
500mg
BID
S/P Cesarean Section
Waiting Final Action 
04/19/2024
CEFUROXIME 1.5GM (VIAL)
04/19/2024
04/20/2024
IV
1.5gm
Prior OR
Prophylaxis
Waiting Final Action 
04/19/2024
CEFUROXIME 1.5GM (VIAL)
04/19/2024
04/20/2024
IV
1.5 G
Q8 X 3 Doses
Sp LTCS
Waiting Final Action 
04/19/2024
CEFUROXIME 500MG (TAB)
04/21/2024
04/28/2024
ORAL
500mg
BID
Sp LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: